DNA Repair DisorderCockayne SyndromeXeroderma PigmentosumTrichothiodystrophy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
6 Months and older
Sex
Any
Study type
Observational
Participants needed
40 (estimated)
Sponsor
University of Minnesota · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This will be a single-center, single-arm, non-interventional natural history study to evaluate the longitudinal clinical course, functional outcome measures, and candidate biomarkers for individuals with DNA repair disorders, including Cockayne syndrome (CS), xeroderma pigmentosum (XP), and trichothiodystrophy (TTD).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Cockayne syndrome (CS), xeroderma pigmentosum (XP), or trichothiodystrophy (TTD), based on genetic testing and/or key clinical characteristics l characteristics
* Has one or more of the following neurodevelopmental or neurological complications
* Gross motor delay…
Inclusion Criteria:
* Diagnosis of Cockayne syndrome (CS), xeroderma pigmentosum (XP), or trichothiodystrophy (TTD), based on genetic testing and/or key clinical characteristics l characteristics
* Has one or more of the following neurodevelopmental or neurological complications
* Gross motor delay (non-ambulatory or started walking after age 18 months)
* Language delay (non-verbal or started talking after 18 months)
* Altered muscle tone (hypertonia, dystonia, hypotonia)
* Gait difficulties, including stiff gait, short stride, frequent falls, use of orthotics, use of walker
* Tremors
* Microcephaly
* Is a family member of an individual with the above condition
* No restrictions regarding current ambulatory status
* Minimum age for enrollment eligibility will be 6 months due to fragility of neonates with severe forms of DNA repair disorders and limitations of motor assessment scales in infants younger than 6 months. There will be no maximum age for enrollment eligibility.
* No restrictions regarding gender, race, or ethnicity.
* Voluntary written consent from the participant if adult capable of consenting or parent/guardian if minor or not capable of consenting
* Written consent of Legally Authorized Representative if enrolling adult lacks capacity to consent
Exclusion Criteria:
* Any prior history of systemic gene or cell-based therapy
* Current participation in an interventional clinical trial
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.